- Home
- VET vs TXG Comparison
VET vs TXG Comparison
Compare VET & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VET
- TXG
- Stock Information
- Founded
- VET 1994
- TXG 2012
- Country
- VET Canada
- TXG United States
- Employees
- VET N/A
- TXG N/A
- Industry
- VET Oil & Gas Production
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- VET Energy
- TXG Industrials
- Exchange
- VET Nasdaq
- TXG Nasdaq
- Market Cap
- VET 1.6B
- TXG 1.5B
- IPO Year
- VET N/A
- TXG 2019
- Fundamental
- Price
- VET $8.92
- TXG $10.90
- Analyst Decision
- VET
- TXG Buy
- Analyst Count
- VET 0
- TXG 16
- Target Price
- VET N/A
- TXG $20.36
- AVG Volume (30 Days)
- VET 973.2K
- TXG 2.9M
- Earning Date
- VET 03-05-2025
- TXG 02-12-2025
- Dividend Yield
- VET 3.91%
- TXG N/A
- EPS Growth
- VET N/A
- TXG N/A
- EPS
- VET N/A
- TXG N/A
- Revenue
- VET $1,344,960,953.00
- TXG $610,785,000.00
- Revenue This Year
- VET $13.17
- TXG $4.38
- Revenue Next Year
- VET $12.55
- TXG $9.08
- P/E Ratio
- VET N/A
- TXG N/A
- Revenue Growth
- VET N/A
- TXG N/A
- 52 Week Low
- VET $8.22
- TXG $10.80
- 52 Week High
- VET $12.79
- TXG $48.42
- Technical
- Relative Strength Index (RSI)
- VET 39.25
- TXG 24.63
- Support Level
- VET $8.92
- TXG $11.43
- Resistance Level
- VET $9.30
- TXG $13.12
- Average True Range (ATR)
- VET 0.28
- TXG 0.98
- MACD
- VET -0.02
- TXG -0.24
- Stochastic Oscillator
- VET 3.85
- TXG 2.27
About VET Vermilion Energy Inc. Common (Canada)
Vermilion Energy Inc is an international oil and gas-producing company. It engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. It derives a majority of its revenue from Canada.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.